Top compounds associated with response to ST18


Feature Type Standardized
Nominal ANOVA
mRNA Cetuximab GDSC1000 pan-cancer AAC -0.17 3e-07
mRNA necrosulfonamide CTRPv2 pan-cancer AAC 0.2 3e-07
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 3e-07
mRNA ABT-263 CTRPv2 pan-cancer AAC 0.18 4e-07
mRNA thapsigargin GDSC1000 pan-cancer AAC -0.18 6e-07
mRNA Vinblastine GDSC1000 pan-cancer AAC -0.18 1e-06
mRNA temsirolimus GDSC1000 pan-cancer AAC -0.17 1e-06
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 1e-06
mRNA Pazopanib FIMM pan-cancer AAC 0.8 1e-06
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 2e-06
Download CSV